These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24766465)

  • 1. Clonal dominance and clonal evolution in a patient with a "chronic myeloid neoplasm": a challenge in management.
    Burgstaller S; Webersinke G; Thaler J
    Leuk Lymphoma; 2015 Jan; 56(1):239-41. PubMed ID: 24766465
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.
    de Conchon MRM; Costa JL; Novaes MMY; Dorlhiac-Llacer PE; de Alencar Fischer Chamone D; Bendit I
    Int J Hematol; 2008 Sep; 88(2):243-245. PubMed ID: 18626727
    [No Abstract]   [Full Text] [Related]  

  • 3. Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.
    Luque Paz D; Ianotto JC; Chauveau A; Guibourg B; Lecucq L; Lippert E; Ugo V
    Ann Hematol; 2016 Jan; 95(2):349-50. PubMed ID: 26459144
    [No Abstract]   [Full Text] [Related]  

  • 4. JAK2-V617F and BCR-ABL--double jeopardy?
    Krämer A
    Leuk Res; 2008 Oct; 32(10):1489-90. PubMed ID: 18439674
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation.
    Caocci G; Atzeni S; Orrù N; Littera R; Culurgioni F; Marongiu F; La Nasa G
    Leuk Res; 2010 Jan; 34(1):e27-9. PubMed ID: 19748671
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.
    Xu W; Chen B; Tong X
    Int J Hematol; 2014 Jan; 99(1):87-90. PubMed ID: 24293258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report.
    Ursuleac I; Colita A; Adam T; Jardan C; Ilea A; Coriu D
    J Med Life; 2013 Mar; 6(1):34-7. PubMed ID: 23599815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.
    Cambier N; Renneville A; Cazaentre T; Soenen V; Cossement C; Giraudier S; Grardel N; Laï JL; Rose C; Preudhomme C
    Leukemia; 2008 Jul; 22(7):1454-5. PubMed ID: 18288134
    [No Abstract]   [Full Text] [Related]  

  • 9. Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment.
    Park SH; Chi HS; Cho YU; Jang S; Park CJ; Kim DY; Lee JH; Lee KH
    Ann Lab Med; 2013 May; 33(3):229-32. PubMed ID: 23667855
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation.
    Hussein K; Bock O; Theophile K; Seegers A; Arps H; Basten O; Grips KH; Franz-Werner J; Büsche G; Kreipe H
    Leukemia; 2008 May; 22(5):1059-62. PubMed ID: 17972958
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipocalin-2 is associated with modulation of disease phenotype in a patient with concurrent JAK2-V617F and BCR-ABL mutation.
    Nadarajan VS; Ang CH; Bee PC
    Eur J Haematol; 2012 Feb; 88(2):175-8. PubMed ID: 21950422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics.
    McCarron SL; Haslam K; Crampe M; Langabeer SE
    Lab Hematol; 2012 Dec; 18(4):20-1. PubMed ID: 23253862
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights into JAK2-V617F mutation in CML.
    Bocchia M; Vannucchi AM; Gozzetti A; Guglielmelli P; Poli G; Crupi R; Defina M; Bosi A; Francesco L
    Lancet Oncol; 2007 Oct; 8(10):864-6. PubMed ID: 17913657
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation.
    Pingali SR; Mathiason MA; Lovrich SD; Go RS
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):E25-9. PubMed ID: 19858050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL mutations in chronic myeloid leukemia - not only detection.
    Polakova KM; Zmekova V; Rulcova J; Klamova H; Zemanova Z; Moravcova J
    Leuk Lymphoma; 2008 Aug; 49(8):1620-2. PubMed ID: 18452092
    [No Abstract]   [Full Text] [Related]  

  • 16. Insights into JAK2-V617F mutation in CML.
    Büsche G; Hussein K; Bock O; Kreipe H
    Lancet Oncol; 2007 Oct; 8(10):863-4. PubMed ID: 17913656
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
    Cavelier L; Ameur A; Häggqvist S; Höijer I; Cahill N; Olsson-Strömberg U; Hermanson M
    BMC Cancer; 2015 Feb; 15():45. PubMed ID: 25880391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia.
    Preuner S; Mitterbauer G; Mannhalter C; Herndlhofer S; Sperr WR; Valent P; Lion T
    Eur J Cancer; 2012 Jan; 48(2):233-6. PubMed ID: 21955823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).
    Mark HF; Sokolic RA; Mark Y
    Exp Mol Pathol; 2006 Aug; 81(1):1-7. PubMed ID: 16729999
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis.
    Jallades L; Hayette S; Tigaud I; Johnston A; Coiffier B; Magaud JP; Ffrench M
    Leuk Res; 2008 Oct; 32(10):1608-10. PubMed ID: 18448166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.